Nanoparticles - Metal & Metal Oxides Market In Healthcare By Type (Gold, Silver, Iron Oxide, Alumina, Gadolinium, Cerium), By Application (In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro assays), & Segment Forecasts, 2013 - 2025
The global nanoparticles - metal & metal oxides market in healthcare is anticipated to reach USD 80.74 billion by 2025, according to a new report by Grand View Research, Inc. Several nanotechnologies based medicines have been put forward for approval by the FDA which is anticipated to propel growth.
Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applications with particular emphasis in therapy and diagnostics. This has resulted into the significant production of metal oxide particles that hold potential utility in human medicine.
Remarkable evolution has been made in nanoparticle based medicines for theranostic applications in disease management. Diverse metals have been used for development of medicines with a promise to optimize the efficacy of nanomedicines and to improve the current standard of medical and clinical practices.
These particles are recognized to have major applications in drug delivery, diagnostic products, biomarker discovery, and product packaging. Widespread application spectrum of these particles in maintaining human health is expected to dramatically impact the progress of this market in the coming years.
Moreover, metal oxides are observed to have significant role in cancer treatment. Nanoparticle-augmented systems enable high-concentration targeted drug delivery to cancer cells, which in turn, is expected to enhance the usage rate of metal nanoparticles for cancer treatment. Development of drug delivery strategies using nanoparticle approaches are expected to bring about changes effective for cancer treatment.
However, prolonged exposure of nanoparticles adversely affects the human health as well environment thereby restraining their adoption rate. These products are involved in autophagy, oxidative stress, lysosome dysfunction, and the activation of certain signaling pathways, thereby exhibiting toxicity for human health.
Further key findings from the report suggest:
Presence of untapped potential in alumina and alumina oxide particles is anticipated to create immense opportunities
Aluminum oxide in combination with polymeric membranes is studied for enhancement of drug delivery owing to its high porosity property displayed in the membranes
This enhanced efficacy of the membrane performance by the addition of alumina nanoparticles to polymeric membranes is projected to increase its adoption
Approval of various nanoparticle composition and surface properties for clinical diagnostics and treatment of viral infections is anticipated drive market demand
In-vivo imaging dominated the market with respect to revenue share
Use of antibody conjugated to Au nanorods Raman spectrum with polarized, sharpened, and enhanced results can be attributed for larger revenue share
Oncology dominated over a decade and is projected to sustain its share over the forecast period.
Rising incidence of cancer and other chronic multi-drug resistant diseases pronounces the demand for these particles.
Aforementioned factor is anticipated to drive targeted delivery with fastest YoY growth
Asia Pacific is projected to showcase lucrative progress in the coming years
Key countries in the region are working to enhance the patient’s reach to nanotechnology-based solutions
Moreover, continuous support from the government bodies pertaining to initiation of new projects is expected to play crucial role for projected CAGR
Key players contributing in this market are Pfizer Inc., Brigham Women's Hospital (BWH), Immunolight LLC, nanoComposix, Nanobiotix, Nanospectra Biosciences, Inc, Merck KGaA, and AstraZeneca
These participants are investing in development of the product portfolio that can target the chronic disorders
Arrowhead Pharmaceuticals, Cytimmune Sciences, Inc, Nanobiotix, Celgene Corporation, Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE), and BIND Biosciences are few companies that have products in the pipeline phase
Success of nanomedicine has prompted the development of enhanced nanomaterials for clinical applications with particular emphasis in therapy and diagnostics. This has resulted into the significant production of metal oxide particles that hold potential utility in human medicine.
Remarkable evolution has been made in nanoparticle based medicines for theranostic applications in disease management. Diverse metals have been used for development of medicines with a promise to optimize the efficacy of nanomedicines and to improve the current standard of medical and clinical practices.
These particles are recognized to have major applications in drug delivery, diagnostic products, biomarker discovery, and product packaging. Widespread application spectrum of these particles in maintaining human health is expected to dramatically impact the progress of this market in the coming years.
Moreover, metal oxides are observed to have significant role in cancer treatment. Nanoparticle-augmented systems enable high-concentration targeted drug delivery to cancer cells, which in turn, is expected to enhance the usage rate of metal nanoparticles for cancer treatment. Development of drug delivery strategies using nanoparticle approaches are expected to bring about changes effective for cancer treatment.
However, prolonged exposure of nanoparticles adversely affects the human health as well environment thereby restraining their adoption rate. These products are involved in autophagy, oxidative stress, lysosome dysfunction, and the activation of certain signaling pathways, thereby exhibiting toxicity for human health.
Further key findings from the report suggest:
Presence of untapped potential in alumina and alumina oxide particles is anticipated to create immense opportunities
Aluminum oxide in combination with polymeric membranes is studied for enhancement of drug delivery owing to its high porosity property displayed in the membranes
This enhanced efficacy of the membrane performance by the addition of alumina nanoparticles to polymeric membranes is projected to increase its adoption
Approval of various nanoparticle composition and surface properties for clinical diagnostics and treatment of viral infections is anticipated drive market demand
In-vivo imaging dominated the market with respect to revenue share
Use of antibody conjugated to Au nanorods Raman spectrum with polarized, sharpened, and enhanced results can be attributed for larger revenue share
Oncology dominated over a decade and is projected to sustain its share over the forecast period.
Rising incidence of cancer and other chronic multi-drug resistant diseases pronounces the demand for these particles.
Aforementioned factor is anticipated to drive targeted delivery with fastest YoY growth
Asia Pacific is projected to showcase lucrative progress in the coming years
Key countries in the region are working to enhance the patient’s reach to nanotechnology-based solutions
Moreover, continuous support from the government bodies pertaining to initiation of new projects is expected to play crucial role for projected CAGR
Key players contributing in this market are Pfizer Inc., Brigham Women's Hospital (BWH), Immunolight LLC, nanoComposix, Nanobiotix, Nanospectra Biosciences, Inc, Merck KGaA, and AstraZeneca
These participants are investing in development of the product portfolio that can target the chronic disorders
Arrowhead Pharmaceuticals, Cytimmune Sciences, Inc, Nanobiotix, Celgene Corporation, Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE), and BIND Biosciences are few companies that have products in the pipeline phase
CHAPTER 1 RESEARCH METHODOLOGY
1.1 Information Procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 NANOPARTICLES - METAL & METAL OXIDES MARKET VARIABLES, TRENDS& SCOPE
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Substantial number of nanoparticle-based therapeutics and pharmaceuticals in R&D
3.1.1.2 Growing utility potential of metal nanoparticles in cancer and other diseases treatment
3.1.1.3 Rapid advances in analytical methods for detection and evaluation of nanoparticles
3.1.2 Market Restraint Analysis
3.1.2.1 Toxicity and environmental risks of metal nanomaterials
3.1.2.2 Regulatory issues pertaining to the use and approval of metal nanoparticles
3.2 Penetration & growth prospect mapping for type of nanoparticles, 2016
3.3 Nanoparticles - Metal & Metal Oxides Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
3.5 Metal & Metal Oxide Nanoparticles Pipeline Analysis
3.5.1 Arrowhead Pharmaceuticals
3.5.2 Nanobiotix
3.5.3 BIND Biosciences
3.5.4 CELGENE CORPORATION
3.5.5 CYTIMMUNE SCIENCES, INC
3.5.6 Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE)
3.5.7 Centers of Cancer Nanotechnology Excellence
CHAPTER 4 NANOPARTICLES - METAL & METAL OXIDES: TYPE ESTIMATES & TREND ANALYSIS
4.1 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
4.2 Gold Nanoparticles
4.2.1 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.3 Silver Nanoparticles
4.3.1 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.4 Iron Oxide Nanoparticles
4.4.1 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.5 Alumina Nanoparticles
4.5.1 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.6 Gadolinium oxide nanoparticles
4.6.1 Global gadolinium oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.7 Others
4.7.1 Global other metal nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
CHAPTER 5 NANOPARTICLES - METAL & METAL OXIDES: APPLICATION ESTIMATES & TREND ANALYSIS
5.1 Metal & metal oxides nanoparticles in healthcare market: Application movement analysis
5.2 In-vivo Imaging
5.2.1 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
5.3 Targeted Drug Delivery
5.3.1 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
5.4 Proton Therapy
5.4.1 Global proton therapy market, 2013 - 2025 (USD Billion)
5.5 In-vitro Assays
5.5.1 Global in-vitro assays market, 2013 - 2025 (USD Billion)
5.6 Cell & Phantom Imaging
5.6.1 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
CHAPTER 6 NANOPARTICLES - METAL & METAL OXIDES: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE& APPLICATION
6.1 Metal & metal oxides nanoparticles in healthcare market share by region, 2016 & 2025
6.2 North America
6.2.1 Metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.2.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.2.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.3 Europe
6.3.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.3.2 Germany
6.3.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.3.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.3.3 UK
6.3.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.3.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.4.2 Japan
6.4.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.4.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.4.3 China
6.4.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.4.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.5.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.6 Middle East & Africa
6.6.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.6.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Immunolight LLC
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.2 Merck KGaA
7.3.2.1 Company overview
7.3.2.1.1 Sigma-Aldrich Co. LLC
7.3.2.2 Financial performance
7.3.2.2.1 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 CYTIMMUNE SCIENCES, INC.
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 CELGENE CORPORATION
7.3.4.1 Company overview
7.3.4.1.1 Abraxis BioScience, Inc.
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 AstraZeneca
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Brigham and Women's Hospital (BWH)
7.3.6.1 Company overview
7.3.6.1 Financial performance
7.3.6.2 Product benchmarking
7.3.7 Nanoprobes, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.8 Z-MEDICA
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.9 Nanospectra Biosciences, Inc.
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Nanobiotix
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Oxonica
7.3.11.1 Company overview
7.3.11.1.1 Nanoplex Technologies, Inc.
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.12 Pfizer Inc.
7.3.12.1 Company overview
7.3.12.1.1 BIND Therapeutics
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 nanoComposix
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
1.1 Information Procurement
1.2 Data Analysis
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
CHAPTER 3 NANOPARTICLES - METAL & METAL OXIDES MARKET VARIABLES, TRENDS& SCOPE
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Substantial number of nanoparticle-based therapeutics and pharmaceuticals in R&D
3.1.1.2 Growing utility potential of metal nanoparticles in cancer and other diseases treatment
3.1.1.3 Rapid advances in analytical methods for detection and evaluation of nanoparticles
3.1.2 Market Restraint Analysis
3.1.2.1 Toxicity and environmental risks of metal nanomaterials
3.1.2.2 Regulatory issues pertaining to the use and approval of metal nanoparticles
3.2 Penetration & growth prospect mapping for type of nanoparticles, 2016
3.3 Nanoparticles - Metal & Metal Oxides Market - SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis - Porter’s
3.5 Metal & Metal Oxide Nanoparticles Pipeline Analysis
3.5.1 Arrowhead Pharmaceuticals
3.5.2 Nanobiotix
3.5.3 BIND Biosciences
3.5.4 CELGENE CORPORATION
3.5.5 CYTIMMUNE SCIENCES, INC
3.5.6 Siteman Center of Cancer Nanotechnology Excellence (Washington University CCNE)
3.5.7 Centers of Cancer Nanotechnology Excellence
CHAPTER 4 NANOPARTICLES - METAL & METAL OXIDES: TYPE ESTIMATES & TREND ANALYSIS
4.1 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
4.2 Gold Nanoparticles
4.2.1 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.3 Silver Nanoparticles
4.3.1 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.4 Iron Oxide Nanoparticles
4.4.1 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.5 Alumina Nanoparticles
4.5.1 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.6 Gadolinium oxide nanoparticles
4.6.1 Global gadolinium oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
4.7 Others
4.7.1 Global other metal nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
CHAPTER 5 NANOPARTICLES - METAL & METAL OXIDES: APPLICATION ESTIMATES & TREND ANALYSIS
5.1 Metal & metal oxides nanoparticles in healthcare market: Application movement analysis
5.2 In-vivo Imaging
5.2.1 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
5.3 Targeted Drug Delivery
5.3.1 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
5.4 Proton Therapy
5.4.1 Global proton therapy market, 2013 - 2025 (USD Billion)
5.5 In-vitro Assays
5.5.1 Global in-vitro assays market, 2013 - 2025 (USD Billion)
5.6 Cell & Phantom Imaging
5.6.1 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
CHAPTER 6 NANOPARTICLES - METAL & METAL OXIDES: REGIONAL ESTIMATES & TREND ANALYSIS, BY TYPE& APPLICATION
6.1 Metal & metal oxides nanoparticles in healthcare market share by region, 2016 & 2025
6.2 North America
6.2.1 Metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
6.2.2 U.S.
6.2.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.2.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.2.3 Canada
6.2.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.2.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.3 Europe
6.3.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.3.2 Germany
6.3.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.3.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.3.3 UK
6.3.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.3.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.4 Asia Pacific
6.4.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.4.2 Japan
6.4.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.4.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.4.3 China
6.4.3.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.4.3.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.5 Latin America
6.5.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.5.2 Brazil
6.5.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.5.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
6.6 Middle East & Africa
6.6.1 Metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
6.6.2 South Africa
6.6.2.1 Metal & metal oxides nanoparticles in healthcare market, by type, 2013 - 2025 (USD Billion)
6.6.2.2 Metal & metal oxides nanoparticles in healthcare market, by application, 2013 - 2025 (USD Billion)
CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 Strategy framework
7.2 Market participation categorization
7.3 Company Profiles
7.3.1 Immunolight LLC
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.2 Merck KGaA
7.3.2.1 Company overview
7.3.2.1.1 Sigma-Aldrich Co. LLC
7.3.2.2 Financial performance
7.3.2.2.1 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 CYTIMMUNE SCIENCES, INC.
7.3.3.1 Company overview
7.3.3.2 Financial performance
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 CELGENE CORPORATION
7.3.4.1 Company overview
7.3.4.1.1 Abraxis BioScience, Inc.
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 AstraZeneca
7.3.5.1 Company overview
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Brigham and Women's Hospital (BWH)
7.3.6.1 Company overview
7.3.6.1 Financial performance
7.3.6.2 Product benchmarking
7.3.7 Nanoprobes, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.8 Z-MEDICA
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.9 Nanospectra Biosciences, Inc.
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Nanobiotix
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Oxonica
7.3.11.1 Company overview
7.3.11.1.1 Nanoplex Technologies, Inc.
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.12 Pfizer Inc.
7.3.12.1 Company overview
7.3.12.1.1 BIND Therapeutics
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 nanoComposix
7.3.13.1 Company overview
7.3.13.2 Financial performance
7.3.13.3 Product benchmarking
LIST OF TABLES
Table 1 Clinical studies for metal nanoparticles based therapeutic solutions in 2015
Table 2 Search results of the U.S. databases using the term “nanoparticle” in combination with other terms
Table 3 Metal and metal oxide nanoparticles and cancer research
Table 4 In vitro/in vivo studies on toxicity of various types of metal nanoparticles
Table 5 Gold nanoparticles and their applications
Table 6 Role of superparamagnetic iron oxide nanoparticles in different areas of Magnetic Resonance Imaging (MRI)
Table 7 Active cancer-targeting strategies of magnetic nanoparticle
Table 8 North America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 9 North America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 10 North America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 11 North America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 12 Patent applicant for nanotechnology based therapeutics
Table 13 U.S. metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 14 U.S. metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 15 U.S. metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 16 U.S. metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 17 Nanotechnology organizations which are involved in publishing nanoscience based articles
Table 18 Canada metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 19 Canada metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 20 Canada metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 21 Canada metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 22 Europe metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 23 Europe metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 24 Europe metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 25 Europe metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 26 Germany metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 27 Germany metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 28 Germany metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 29 Germany metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 30 UK metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 31 UK metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 32 UK metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 33 UK metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 34 Asia Pacific metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 35 Asia Pacific metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 36 Asia Pacific metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 37 Asia Pacific metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 38 Japan metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 39 Japan metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 40 Japan metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 41 Japan metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 42 China metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 43 China metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 44 China metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 45 China metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 46 Latin America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 47 Latin America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 48 Latin America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 49 Latin America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 50 Brazil metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 51 Brazil metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 52 Brazil metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 53 Brazil metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 54 MEA metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 55 MEA metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 56 MEA metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 57 MEA metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 58 South Africa metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 59 South Africa metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 60 South Africa metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 61 South Africa metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 1 Clinical studies for metal nanoparticles based therapeutic solutions in 2015
Table 2 Search results of the U.S. databases using the term “nanoparticle” in combination with other terms
Table 3 Metal and metal oxide nanoparticles and cancer research
Table 4 In vitro/in vivo studies on toxicity of various types of metal nanoparticles
Table 5 Gold nanoparticles and their applications
Table 6 Role of superparamagnetic iron oxide nanoparticles in different areas of Magnetic Resonance Imaging (MRI)
Table 7 Active cancer-targeting strategies of magnetic nanoparticle
Table 8 North America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 9 North America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 10 North America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 11 North America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 12 Patent applicant for nanotechnology based therapeutics
Table 13 U.S. metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 14 U.S. metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 15 U.S. metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 16 U.S. metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 17 Nanotechnology organizations which are involved in publishing nanoscience based articles
Table 18 Canada metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 19 Canada metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 20 Canada metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 21 Canada metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 22 Europe metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 23 Europe metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 24 Europe metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 25 Europe metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 26 Germany metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 27 Germany metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 28 Germany metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 29 Germany metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 30 UK metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 31 UK metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 32 UK metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 33 UK metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 34 Asia Pacific metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 35 Asia Pacific metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 36 Asia Pacific metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 37 Asia Pacific metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 38 Japan metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 39 Japan metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 40 Japan metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 41 Japan metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 42 China metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 43 China metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 44 China metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 45 China metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 46 Latin America metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 47 Latin America metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 48 Latin America metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 49 Latin America metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 50 Brazil metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 51 Brazil metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 52 Brazil metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 53 Brazil metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 54 MEA metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 55 MEA metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 56 MEA metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 57 MEA metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
Table 58 South Africa metal & metal oxides nanoparticles market estimates, by type, 2013 - 2016 (USD Billion)
Table 59 South Africa metal & metal oxides nanoparticles market forecasts, by type, 2017 - 2025 (USD Billion)
Table 60 South Africa metal & metal oxides nanoparticles in healthcare market estimates, by application, 2013 - 2016 (USD Billion)
Table 61 South Africa metal & metal oxides nanoparticles in healthcare market forecasts, by application, 2017 - 2025 (USD Billion)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping for type of nanoparticles, 2016
Fig. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Metal & metal oxides nanoparticles in healthcare market type outlook key takeaways
Fig. 16 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
Fig. 17 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 18 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 19 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 20 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 21 Global gadolinium oxide nanoparticles market, 2013 - 2025 (USD Billion)
Fig. 22 Global other metal nanoparticles market, 2013 - 2025 (USD Billion)
Fig. 23 Metal & metal oxides nanoparticles in healthcare market: Application outlook key takeaways
Fig. 24 Global metal & metal oxides nanoparticles in healthcare: Application movement analysis
Fig. 25 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
Fig. 26 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
Fig. 27 Global proton therapy market, 2013 - 2025 (USD Billion)
Fig. 28 Global in-vitro assays market, 2013 - 2025 (USD Billion)
Fig. 29 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
Fig. 30 Regional market place: Key takeaway
Fig. 31 Metal & metal oxides nanoparticles in healthcare regional outlook, 2016 & 2025
Fig. 32 North America metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
Fig. 33 U.S. metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
Fig. 34 Canada. metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 35 Europe metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 36 Germany metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 37 UK metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 38 Asia Pacific metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 39 Japan metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 40 China metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 41 Latin America metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 42 Brazil metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 43 Middle East & Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 44 South Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 45 Strategy framework
Fig. 46 Participant categorization
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market summary
Fig. 8 Market trends & outlook
Fig. 9 Market segmentation & scope
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping for type of nanoparticles, 2016
Fig. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Metal & metal oxides nanoparticles in healthcare market type outlook key takeaways
Fig. 16 Metal & metal oxides nanoparticles in healthcare market: Type movement analysis
Fig. 17 Global gold nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 18 Global silver nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 19 Global iron oxide nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 20 Global alumina nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 21 Global gadolinium oxide nanoparticles market, 2013 - 2025 (USD Billion)
Fig. 22 Global other metal nanoparticles market, 2013 - 2025 (USD Billion)
Fig. 23 Metal & metal oxides nanoparticles in healthcare market: Application outlook key takeaways
Fig. 24 Global metal & metal oxides nanoparticles in healthcare: Application movement analysis
Fig. 25 Global in-vivo imaging market, 2013 - 2025 (USD Billion)
Fig. 26 Global targeted drug delivery market, 2013 - 2025 (USD Billion)
Fig. 27 Global proton therapy market, 2013 - 2025 (USD Billion)
Fig. 28 Global in-vitro assays market, 2013 - 2025 (USD Billion)
Fig. 29 Global cell & phantom imaging market, 2013 - 2025 (USD Billion)
Fig. 30 Regional market place: Key takeaway
Fig. 31 Metal & metal oxides nanoparticles in healthcare regional outlook, 2016 & 2025
Fig. 32 North America metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
Fig. 33 U.S. metal & metal oxides nanoparticles in healthcare market, 2013 - 2025 (USD Billion)
Fig. 34 Canada. metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 35 Europe metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 36 Germany metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 37 UK metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 38 Asia Pacific metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 39 Japan metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 40 China metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 41 Latin America metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 42 Brazil metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 43 Middle East & Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 44 South Africa metal & metal oxides nanoparticles market in healthcare, 2013 - 2025 (USD Billion)
Fig. 45 Strategy framework
Fig. 46 Participant categorization
